Entrada Therapeutics, Inc. - TRDA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Sep 10, 2026 | SCHEDULE 13D/A | — | 9.98% | 38,936,669 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | TCG Crossover GP I, LLC | 2.7% | 1,060,230 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | TCG Crossover Fund I, L.P. | 2.7% | 1,060,230 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Chen Yu | 2.7% | 1,060,230 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.